5-year mortality | Recurrence within 3 years | |||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Age | ||||||
< 65 | 1.0 | 1.0 | ||||
65–74 | 1.2 | (0.8–1.6) | 0.4 | 1.2 | (0.7–2.1) | 0.52 |
75–84 | 1.8 | (1.3–2.5) | 0.00 | 1.0 | (0.6–1.8) | 0.95 |
> 85 | 3.6 | (2.5–5.1) | 0.00 | 0.5 | (0.2–1.3) | 0.15 |
ASA score | ||||||
1–2 | 1.0 | 1.0 | 0.90 | |||
3 | 1.8 | (1.4–2.3) | 0.00 | 1.0 | (0.6–1.5) | 0.50 |
4 | 4.0 | (2.8–5.9) | 0.00 | 1.4 | (0.5–3.7) | 0.60 |
T-stage | ||||||
1–2 | 1.0 | 1.0 | ||||
3 | 1.4 | (0.7–3.0) | 0.34 | 1.1 | (0.3–4.6) | 0.90 |
4 | 2.4 | (1.1–4.9) | 0.2 | 1.4 | (0.3–5.9) | 0.70 |
N-stage | ||||||
0 | 1.0 | 1.0 | ||||
1–2 | 1.6 | (1.2–2.1) | < 0.05 | 2.9 | (1.7–4.9) | < 0.05 |
M-stage | ||||||
0 | 1.0 | |||||
1 | 2.9 | (2.3–3.7) | 0.00 | |||
Surgical specialization | ||||||
CRT | 1.0 | 1.0 | ||||
EST | 1.0 | (0.7–1.3) | 0.88 | 0.7 | (0.4–1.1) | 0.15 |
GST | 1.2 | (0.9–1.6) | 0.24 | 1.3 | (0.8–2.2) | 0.36 |